Jake Javier, a patient in the spinal cord injury stem cell therapy clinical trial It’s always satisfying to see two projects you have supported for a long time do well. That’s particularly true when the projects in question are targeting conditions that have no other effective therapies. This week we learned that a clinical trial … Continue reading Good news for two CIRM-supported therapies
News
The challenges of living with IPEX
Last week the CIRM Board awarded $5.53 million to Dr. Rosa Bacchetta at Stanford to complete the work necessary to conduct a clinical trial for IPEX syndrome. This is a rare disease caused by mutations in the FOXP3 gene which leaves people with the condition vulnerable to immune system attacks on their organs and tissues. … Continue reading The challenges of living with IPEX
How early CIRM support helped an anti-cancer therapy overcome obstacles and help patients
Dr. Catriona Jamieson, UC San Diego When you read about a new drug or therapy being approved to help patients it always seems so simple. Researchers come up with a brilliant idea, test it to make sure it is safe and works, and then get approval from the US Food and Drug Administration (FDA) to … Continue reading How early CIRM support helped an anti-cancer therapy overcome obstacles and help patients
A bridge to the future: training the next generation of stem cell scientists
At CIRM we don’t just invest in stem cell research, we invest in people. One prime example of that is our Bridges to Stem Cell Research program. This is helping train the next generation of scientists by preparing Californian undergraduate and master’s students for careers in stem cell research. The students who go through the … Continue reading A bridge to the future: training the next generation of stem cell scientists
CIRM Team answers your questions about stem cell research
It’s not often you get the chance to ask a group of world class experts any question you like about stem cells and stem cell research, but that’s what we are offering you. We’re going to hold our next Facebook Live “Ask the Stem Cell Team” event focused solely on your questions with answers from … Continue reading CIRM Team answers your questions about stem cell research
CIRM funded research could lead to treatment to prevent recurrence of deadly blood cancer
Chronic myelogenous leukemia Chronic myelogenous leukemia (CML) is a cancer of the white blood cells. It causes them to increase in number, crowd out other blood cells, leading to anemia, infection or heavy bleeding. Up until the early 2000’s the main weapon against CML was chemotherapy, but the introduction of drugs called tyrosine kinase inhibitors … Continue reading CIRM funded research could lead to treatment to prevent recurrence of deadly blood cancer
Predicting the Impact of Stem Cell Cures on Healthcare Burden in California
A new independent report says developing stem cell treatments and cures for some of the most common and deadly diseases could produce multi-billion dollar benefits for California in reduced healthcare costs and improved quality and quantity of life. The report, by researchers at the University of Southern California’s Leonard D. Schaeffer Center for Health Policy … Continue reading Predicting the Impact of Stem Cell Cures on Healthcare Burden in California
New Report Says CIRM Produces Big Economic Boost for California
An independent Economic Impact Report says the California Institute for Regenerative Medicine (CIRM) has had a major impact on California’s economy, creating tens of thousands of new jobs, generating hundreds of millions of dollars in new taxes, and producing billions of dollars in additional revenue for the state. The report, done by Dan Wei and … Continue reading New Report Says CIRM Produces Big Economic Boost for California
When Google turns on you, you know you are in trouble
For years CIRM and others in the stem cell community (hello Paul Knoepfler) have been warning people about the dangers of going to clinics offering unproven and unapproved stem cell therapies. Recently the drum beat of people and organizations coming out in support of that stand has grown louder and louder. Mainstream media – TV … Continue reading When Google turns on you, you know you are in trouble
Moving a great idea targeting diabetes out of the lab and into a company
Tejal Desai in her lab at UCSF: Photo courtesy Todd Dubnicoff It’s always gratifying to see research you have helped support go from being an intriguing idea to something with promise to a product that is now the focus of a company. It’s all the more gratifying if the product in question might one day … Continue reading Moving a great idea targeting diabetes out of the lab and into a company
The Stem Cellar 